CB COSCIENS Biopharma Inc. Stock: price and insider trades · Canada · SEDISource id SEDI:cosciens-biopharma-inc CA · SEDI Mcap CA$7.7M Track the COSCIENS Biopharma Inc. stock price and the full insider trade history of the company, a listed issuer based in Canada. Shares trade on the CA market, under the authority of SEDI. Market capitalisation: €7.7m. The latest transaction was disclosed on 10 August 2026 (56 - Grant of rights). Among the most active insiders: Kosciessa, Ulrich. All data is openly available.
Fundamental score
Ranked 27,861 of 29,064 companies
FCF yld -118%
Earn yld -134%
EV/EBITDA ·
ROE -53%
Gross mgn 35%
Net mgn ·
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 August 2026
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
● 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) · Executives · 4 Aug 2026
11,000 shares Restricted Share Units (RSU) SEDI:4762922 ● 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) · Executives · 4 Aug 2026
Restricted Share Units (RSU) SEDI:4762921 ● 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) · Executives · 4 Aug 2026
● 4 - Director of Issuer · Executives · 4 Aug 2026
6,000 shares Deferred Share Units SEDI:4760209 ● 4 - Director of Issuer · Executives · 30 May 2025
Deferred Share Units SEDI:4760200 ● 4 - Director of Issuer · Executives · 4 Aug 2026
6,000 shares Deferred Share Units SEDI:4758903 ● 4 - Director of Issuer · Executives · 30 May 2025
Deferred Share Units SEDI:4758900 ● 4 - Director of Issuer · Executives · 4 Aug 2026
6,000 shares Deferred Share Units SEDI:4758898 ● 4 - Director of Issuer · Executives · 30 May 2025
Deferred Share Units SEDI:4758896 ● 4 - Director of Issuer · Executives · 4 Aug 2026
6,000 shares Deferred Share Units SEDI:4758895 ● 4 - Director of Issuer · Executives · 3 Jul 2026
3,304 shares Options SEDI:4758893 ● 4 - Director of Issuer · Executives · 3 Jul 2026
10,000 shares Deferred Share Units SEDI:4758891 ● 4 - Director of Issuer · Executives · 4 Aug 2026
6,000 shares Deferred Share Units SEDI:4758887 ● 4 - Director of Issuer · Executives · 3 Jul 2026
3,304 shares Options SEDI:4758882 ● 4 - Director of Issuer · Executives · 3 Jul 2026
8,334 shares Deferred Share Units SEDI:4758878 ● 4 - Director of Issuer · Executives · 3 Jul 2026
1,232 shares Common Shares SEDI:4758874 ● 5 - Senior Officer of Issuer · Executives · 4 Aug 2026
16,000 shares Restricted Share Units (RSU) SEDI:4758870 ● 5 - Senior Officer of Issuer · Executives · 24 Jan 2022
Restricted Share Units (RSU) SEDI:4758868 ● 5 - Senior Officer of Issuer · Executives · 3 Jul 2026
334 shares Options SEDI:4758866 ● 4 - Director of Issuer · Executives · 4 Aug 2026
37,000 shares Restricted Share Units (RSU) SEDI:4758863 ● 4 - Director of Issuer · Executives · 30 May 2025
Restricted Share Units (RSU) SEDI:4758859 ● 4 - Director of Issuer · Executives · 3 Jul 2026
10,458 shares Common Shares SEDI:4758801 About COSCIENS Biopharma Inc. COSCIENS Biopharma Inc. is a biopharmaceutical company listed on the XTSE. It focuses on developing innovative treatments for various diseases.